查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2018633

动物医药市场：2026-2032年全球市场预测（依产品类型、目标动物、治疗领域、给药途径及通路划分）

Veterinary Medicine Market by Product Type, Animal Type, Therapeutic Area, Route Of Administration, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，兽药市场价值将达到 491 亿美元，到 2026 年将成长至 529.7 亿美元，到 2032 年将达到 849.1 亿美元，复合年增长率为 8.13%。

主要市场统计数据
基准年 2025 491亿美元
预计年份：2026年 529.7亿美元
预测年份 2032 849.1亿美元
复合年增长率 (%) 8.13%

对不断发展的动物医药生态系统进行简要概述，重点关注整合医学、预防策略以及决策者的商业性需求。

兽医学领域正处于一个转折点，技术创新、消费者模式的改变以及监管环境的演变正在重塑临床实践、产品开发和分销。本执行摘要简要概述了高阶主管在应对短期挑战和掌握长期策略机会时应考虑的结构性驱动因素、竞争动态及其对业务营运的影响。

诊断主导的护理、数位化管道和本地化供应链如何重新定义兽医领域的产品开发和服务交付。

根本性的变革正在改变兽医服务的提供方式、产品的研发方式以及商业性价值的创造方式。其中一个重大变革是诊断与治疗的融合。快速的即时诊断和先进的影像技术使得早期疗育成为可能，进而推动了对标靶药物和疫苗的需求。利用这些诊断技术的模式正在重塑犬猫等伴侣动物的临床诊疗方案，同时也影响牛、家禽和猪等畜群的健康管理策略。

评估 2025 年美国关税措施对兽药品类整体供应链、采购选择和价格趋势的策略影响。

贸易政策和关税措施的变化将对整个兽药价值链的投入成本、供应链策略和价格趋势产生重大影响。预计美国将于2025年实施或提案征收关税，这将再次给製造商和经销商带来巨大压力，迫使他们重新评估活性药物成分、疫苗组分和诊断设备的筹资策略。这些关税措施往往会增加进口原材料和成品的成本，促使企业探索供应商多元化、近岸外包和长期采购协议等方案。

为了更好地进行决策，我们提供细分市场层面的策略指导，使物种特定需求、产品形式、治疗重点、分销管道和给药途径保持一致。

细緻的市场区隔观点对于将市场趋势转化为可执行的商业计划至关重要。相关人员需要根据动物种类制定差异化的策略：伴侣动物市场，猫狗占据了大部分临床需求和消费者支出；以马为中心的马匹市场，其性能和健康需求独具特色；以及畜牧业市场，包括牛、家禽和猪，规模、生物安全和饲料转化率都会影响产品的采用。每个动物类别都有其独特的购买模式、监管要点和分销管道偏好。

影响全球主要地区监管协调、生产决策和分销策略的区域趋势和跨境因素。

区域趋势对整体兽医行业的管理体制、流通结构和投资重点都产生了显着影响。美洲地区通常拥有成熟的伴侣动物照护生态系统、强大的零售药局网路以及日益普及的数位医疗服务。这些特点支撑了都市区较高的单隻动物医疗支出，并为诊断和处方药创造了极具吸引力的分销管道。相较之下，欧洲、中东和非洲（EMEA）地区则呈现出多样性；许多欧洲市场已建立了完善的法规结构和高标准的兽医体系，而中东和非洲的一些地区则优先考虑畜牧业健康和生物安全，以保护食品供应链。

一项结合产品创新、伙伴关係和商业性灵活性的竞争策略，旨在确保临床应用和兽医领域的永续成长。

兽医领域的竞争格局取决于产品系列、垂直整合和策略伙伴关係关係。主要企业往往将疫苗平台、专有药品和诊断能力等优势与覆盖诊所、药房和线上管道的广泛分销网络和服务相结合。投资于製剂科学和给药技术的企业在使用者便利性和用药依从性方面获得优势，尤其是在慢性病治疗和驱虫药给药方案製定方面。

一系列可操作的策略措施，重点在于诊断、健全的采购系统、通路差异化、物种特异性研发以及与监管机构的合作，将推动商业化成功。

产业领导企业应优先考虑几项影响深远的倡议，以克服复杂性并抓住机会。首先，投资诊断整合和即时数据系统能够实现更精准的治疗决策，减少不合理使用抗生素，并有助于向支付方和终端用户传递价值。这需要协调投资于临床检测、影像技术和分析能力，以便将临床征兆转化为可执行的治疗方案。

为了获得可立即用于决策的实用见解，我们采用以证据为基础的研究途径，结合质性访谈、二次检验和情境压力测试。

本执行摘要所依据的研究采用了多种调查方法，以确保其可靠性和有效性。主要研究包括：对伴侣动物、马匹和牲畜领域的兽医进行结构化访谈；与製药、疫苗和诊断行业的资深商业领袖进行讨论；以及与透过线上、零售药局和诊所管道运营的分销合作伙伴进行咨询。这些访谈提供了关于产品推广驱动因素、给药偏好和通路经济效益等方面的实地观点。

本报告将物种特定优先事项、不断演变的分销模式和政策主导的供应链应对措施联繫起来，并将它们整合为清晰的策略见解，供领导者参考。

总而言之，兽医学的格局正在朝着以诊断主导的综合医疗模式发展，并以数位化管道和在地化生产策略为支持。从猫狗等伴侣动物到马匹，甚至牛、家禽、猪等生产动物，不同物种的差异需要在产品开发、监管合作和分销设计等各个阶段采取量身定制的方法。产品创新日益着重于增强诊断能力、开发先进的疫苗平台以及研发符合实际应用限制的便利配方。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章动物医药市场：依产品类型划分

  • 诊断药物
    • 诊断影像
    • 感染疾病
  • 药用饲料添加剂
  • 製药
    • 学名药
    • 非处方药
    • 处方药
  • 疫苗
    • 失活
    • 活病毒疫苗
    • 重组

第九章动物医药市场：依动物类型划分

  • 伴侣动物
    • 猫
    • 狗
  • 马
  • 家畜
    • 牛
    • 家禽
    • 猪

第十章动物医药市场：依治疗领域划分

  • 感染疾病物
    • 抗生素
    • 抗真菌药物
    • 抗病毒药物
  • 抗发炎药
  • 循环系统
  • 驱虫
    • 体外寄生虫控制药物
    • 体内寄生虫控制药物

第十一章动物医药市场：依给药途径划分

  • 吸入
  • 注射药物
  • 口服
  • 外用

第十二章动物医药市场：依分销管道划分

  • 网路商店
  • 药局
  • 动物医院

第十三章动物医药市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章动物医药市场：依类别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章动物医药市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国动物医药市场

第十七章：中国动物医药市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Archer-Daniels-Midland Company
  • Biogenesis Bago SA
  • Biopharm company
  • Biowet Pulawy sp. z oo
  • Brovapharma
  • CH Boehringer Sohn AG & Co KG
  • Ceva Sante Animale
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Evonik Industries AG
  • Hester Biosciences Limited
  • Indian Immunologicals Ltd.
  • Intracin Pharmaceutical Private Limited
  • JoinHub Pharma
  • Merck & Co Inc.
  • Nam Pharma Sdn Bhd
  • NAPHAVET Co., Ltd.
  • Neogen Corporation
  • Nutreco NV
  • Phibro Animal Health Corporation
  • Sykes Vet International Pty Ltd.
  • TRAVETCO
  • Vetoquinol SA
  • Vetpharma Animal Health SL
  • Vetsintez LLC
  • Virbac SA
  • Weefsel Pharma
  • Zoetis Inc.
Product Code: MRR-221461476D1E

The Veterinary Medicine Market was valued at USD 49.10 billion in 2025 and is projected to grow to USD 52.97 billion in 2026, with a CAGR of 8.13%, reaching USD 84.91 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 49.10 billion
Estimated Year [2026] USD 52.97 billion
Forecast Year [2032] USD 84.91 billion
CAGR (%) 8.13%

A concise orientation to the evolving veterinary medicine ecosystem emphasizing integrated care, preventive strategies, and commercial imperatives for decision-makers

The veterinary medicine sector stands at an inflection point where technological innovation, shifting consumption patterns, and evolving regulatory landscapes are reshaping clinical practice, product development, and distribution. This executive summary provides a concise synthesis of the structural drivers, competitive dynamics, and operational implications that senior leaders must consider to navigate near-term disruptions and longer-term strategic opportunities.

Over recent years, veterinary care has moved beyond episodic treatment toward integrated animal health management that emphasizes preventive care, diagnostics-led decision making, and data-driven outcomes. These trends are especially pronounced in companion animal care, where pet owners increasingly prioritize convenience, digital engagement, and higher standards of therapeutic outcomes. At the same time, livestock and equine segments are experiencing heightened scrutiny on biosecurity, productivity, and feed efficiency, prompting shifts in product mix and service delivery.

Consequently, corporate leaders must align R&D priorities, go-to-market models, and supply chain resilience with these multi-vector changes. This introduction frames the subsequent sections, which explore transformative shifts across the ecosystem, tariff-related trade implications projected for 2025, segmentation-level insights, regional dynamics, competitive positioning, actionable recommendations, and the research approach underpinning the findings. The narrative purposefully integrates species, product, distribution, therapeutic, and administration dimensions so that stakeholders can translate strategic implications into practical initiatives.

How diagnostics-led care, digital channels, and supply chain localization are redefining product development and service delivery across veterinary medicine

Fundamental shifts are transforming how veterinary health services are delivered, how products are developed, and how commercial value is captured. One major change is the convergence of diagnostics and therapeutics: faster, point-of-care diagnostics and advanced imaging are enabling earlier intervention, which in turn drives demand for targeted pharmaceuticals and vaccines. This diagnostic-enabled model is reshaping clinical protocols for companion animals such as cats and dogs, while also informing herd health strategies for cattle, poultry, and swine.

Another transformative movement is the rapid adoption of digital and remote care models. Telemedicine and digital triage platforms have become a viable complement to traditional clinic visits, particularly in urban companion animal markets and in regions where clinic density is low. These digital capabilities are altering the distribution landscape, creating opportunities for online stores to partner with pharmacies and veterinary clinics to provide integrated care journeys. They also permit more efficient chronic disease management across therapeutic areas such as anti-infectives and anti-inflammatories.

Supply chain localization and manufacturing innovation constitute a third major shift. In response to geopolitical uncertainty and pandemic lessons, firms are accelerating investments in localized formulation and fill-finish capacity, as well as in alternative routes of administration such as injectables, oral formulations, and topical therapies that align with field conditions. Finally, there is a rising emphasis on formulation science and novel vaccine platforms that address species-specific needs-ranging from recombinant vaccines for equine applications to improved inactivated vaccine stability for livestock-thereby changing product development roadmaps and regulatory engagement strategies.

Assessing the strategic consequences of United States tariff measures in 2025 for supply chains, sourcing choices, and pricing dynamics across veterinary product categories

Trade policy changes and tariff actions can materially influence input costs, supply chain strategies, and pricing dynamics across the veterinary medicines value chain. In the context of tariffs enacted or proposed in the United States in 2025, manufacturers and distributors are facing renewed pressure to reassess sourcing strategies for active pharmaceutical ingredients, vaccine components, and diagnostic equipment. These tariff measures tend to increase landed costs for imported raw materials and finished goods, which encourages firms to evaluate options including supplier diversification, nearshoring, and long-term purchasing agreements.

As companies respond, logistics and inventory strategies will also adapt. Firms may increase safety stock levels or shift to multi-sourcing to mitigate exposure, while contract manufacturers and distributors reassess contractual terms to allocate risk more explicitly. In parallel, pricing discipline becomes critical: firms must consider how to balance cost recovery with competitive positioning, especially in price-sensitive channels such as online stores and pharmacies. For therapeutic categories where alternatives exist-such as generic pharmaceuticals versus brand prescription drugs-tariff-induced cost differentials can accelerate substitution or, conversely, reinforce demand for domestically produced branded solutions.

Regulatory and policy responses will further shape outcomes. Policymakers may implement targeted exemptions for essential veterinary products to preserve animal health and food security, or they may incentivize domestic production through tax credits and grants. Therefore, senior leaders should monitor trade policy developments closely while engaging with industry associations and regulatory bodies to advocate for predictable trade frameworks that protect both animal health and sectoral resilience.

Segment-level strategic guidance that aligns species-specific needs, product modalities, therapeutic priorities, distribution channels, and routes of administration for better decision-making

A nuanced segmentation view is indispensable for translating market dynamics into actionable commercial plans. Based on animal type, stakeholders must differentiate strategies across companion animal segments-where cats and dogs dominate clinical demand and consumer spending-from equine markets, which have unique performance and wellness needs centered on horses, and livestock sectors comprising cattle, poultry, and swine where scale, biosecurity, and feed efficiency drive product adoption. Each animal category presents distinct purchasing patterns, regulatory touchpoints, and channel preferences.

Product type segmentation reveals divergent innovation and commercialization pathways. Diagnostics encompass imaging modalities and infectious disease assays that are increasingly deployed at point of care, influencing downstream pharmaceutical and vaccine utilization. Medicated feed additives target production efficiency in livestock, requiring close alignment with feed manufacturers and farm management systems. Pharmaceuticals span generic drugs, over-the-counter remedies, and prescription medicines, each with different regulatory burdens and margin profiles. Vaccines include inactivated, live attenuated, and recombinant platforms, and they demand specialized cold-chain and administration capabilities.

Distribution channel segmentation-consisting of online stores, pharmacies, and veterinary clinics-determines customer access models and margin structures. Online channels excel in convenience and subscription models, pharmacies provide retail reach for OTC products, and clinics combine diagnosis with point-of-care treatment. Therapeutic area distinctions across anti-infectives, anti-inflammatories, cardiovascular agents, and parasiticides inform R&D prioritization; within anti-infectives, antibiotics, antifungals, and antivirals each require targeted stewardship strategies, while parasiticides separate into ectoparasiticides and endectocides with differing administration regimens. Route of administration considerations-covering inhalation, injectable, oral, and topical formats-further influence product design, user training needs, and adoption curves.

Regional dynamics and cross-border considerations that influence regulatory alignment, manufacturing decisions, and distribution strategies across major global regions

Regional dynamics materially shape regulatory regimes, distribution architectures, and investment priorities across veterinary medicine. In the Americas, markets often feature mature companion animal care ecosystems, a strong retail pharmacy presence, and expanding digital health adoption; these characteristics support higher per-animal spend in urban centers and create attractive channels for diagnostics and prescription pharmaceuticals. In contrast, the Europe, Middle East & Africa region displays heterogeneity, with advanced regulatory frameworks and high veterinary standards in many European markets, while certain Middle East and African jurisdictions prioritize livestock health and biosecurity to safeguard food supply chains.

Asia-Pacific is marked by rapid modernization of veterinary services, with growing investment in manufacturing capacity and rising demand for both companion and production animal products. Across all regions, supply chain resilience and regulatory harmonization remain salient priorities, especially for vaccines and biologics that require cold-chain integrity and stringent quality controls. Regional trade agreements and local manufacturing incentives influence where companies choose to site production and distribution hubs, and they affect how firms design market entry strategies that balance speed to market with compliance and cost efficiency.

Consequently, regional leaders and global teams must coordinate closely; successful approaches integrate local market intelligence, regulatory affairs expertise, and partnerships with regional distributors, while also leveraging center-led capabilities in R&D and manufacturing to maintain quality and scale economies.

Competitive strategies that combine product innovation, partnerships, and commercial agility to secure clinical adoption and sustainable growth in veterinary medicine

Competitive positioning in veterinary medicine is shaped by product portfolios, vertical integration, and strategic partnerships. Leading firms tend to combine strengths in vaccine platforms, proprietary pharmaceuticals, and diagnostic capabilities with broad distribution networks and service offerings that span clinics, pharmacies, and online channels. Companies investing in formulation science and delivery technologies secure advantages in user convenience and adherence, particularly for chronic therapeutic areas and parasiticide regimens.

Collaboration remains a key tactic: alliances with feed producers, diagnostic innovators, and contract manufacturing organizations accelerate route-to-market for medicated feed additives and specialty biologics. Licensing and co-development agreements are common for bringing recombinant vaccines and advanced diagnostics to market efficiently, while strategic acquisitions can fill capability gaps in imaging or point-of-care assay technologies. Additionally, firms that proactively engage in antimicrobial stewardship and transparent supply chain practices earn greater trust among regulators, veterinarians, and end customers.

Finally, agility in commercial models-such as subscription services for chronic disease management, bundled diagnostics-therapy offerings for clinics, and direct-to-consumer e-commerce strategies for OTC products-differentiates market leaders from fast followers. Investment in real-world evidence generation and veterinarian education programs further strengthens clinical adoption and long-term brand loyalty.

A pragmatic set of strategic moves focused on diagnostics, resilient sourcing, channel differentiation, species-aligned R&D, and regulatory engagement to drive commercialization success

Industry leaders should prioritize a few high-impact initiatives to navigate complexity and capture opportunities. First, investing in diagnostic integration and real-time data systems will enable more precise therapeutic decisions, reduce inappropriate antimicrobial use, and support value communication to payers and end users. This requires coordinated investments in point-of-care testing, imaging capabilities, and analytics that translate clinical signals into actionable protocols.

Second, companies should reassess sourcing and manufacturing footprints to mitigate tariff and geopolitical risks. Where feasible, nearshoring or dual-sourcing strategies for critical inputs, along with long-term supplier partnerships, will enhance resilience without sacrificing cost competitiveness. Third, firms need to adopt differentiated distribution strategies that exploit the strengths of online channels, pharmacy networks, and clinic relationships; this means creating channel-specific value propositions and service models that reflect distinct customer journeys.

Fourth, aligning R&D pipelines with species-specific needs and administration preferences will improve adoption rates. Prioritizing formulations that simplify administration for owners and farm staff, and advancing vaccine platforms with improved stability, will lower barriers to use. Lastly, proactive regulatory engagement and participation in stewardship initiatives will protect product credibility and enable smoother market access. Together, these actions form a pragmatic roadmap for translating insight into execution.

An evidence-based research approach combining qualitative interviews, secondary validation, and scenario stress-testing to derive practical, decision-ready insights

The research underpinning this executive summary combines multiple methodological approaches to ensure reliability and relevance. Primary qualitative research included structured interviews with veterinarians across companion, equine, and livestock practices, discussions with senior commercial leaders in pharmaceuticals, vaccines, and diagnostics, and consultations with distribution partners operating online, retail pharmacy, and clinic channels. These interviews provided frontline perspectives on adoption drivers, administration preferences, and channel economics.

Secondary analysis drew on peer-reviewed literature, regulatory guidance, industry technical standards, and public company disclosures to validate trends in product innovation, manufacturing capacity, and policy developments. Trade policy and supply chain assessments incorporated publicly available tariff announcements and government statements to model likely operational responses without producing quantitative market estimates. Cross-validation exercises were used to triangulate insights across species, product types, therapeutic areas, and regions to reduce bias and enhance applicability.

Finally, the methodology emphasized practical applicability: findings were stress-tested through scenario workshops with commercial and regulatory experts to refine strategic recommendations and to ensure that suggested actions are feasible within typical organizational constraints and timelines.

Concluding synthesis that links species-specific priorities, evolving distribution models, and policy-driven supply chain responses into clear strategic implications for leaders

In summary, the veterinary medicine landscape is evolving toward integrated, diagnostic-led care supported by digital channels and localized manufacturing strategies. Species differences-from companion animals such as cats and dogs to horses and to production animals like cattle, poultry, and swine-require tailored approaches across product development, regulatory engagement, and distribution design. Product innovation is increasingly centered on diagnostic enablement, advanced vaccine platforms, and user-friendly formulations that match real-world administration constraints.

Trade policy shifts, including tariff actions in major markets, are prompting companies to reconfigure sourcing and inventory strategies while engaging with policymakers to safeguard essential animal health products. Regionally differentiated market dynamics underscore the need for market entry and manufacturing decisions that reflect local regulatory environments and logistical realities across the Americas, Europe, Middle East & Africa, and Asia-Pacific. For commercial leaders, the combination of competitive collaboration, investment in point-of-care capabilities, and disciplined regulatory engagement presents a coherent path to sustain growth and mitigate risk.

Taken together, these conclusions provide a strategic lens for executives to prioritize investments, align cross-functional teams, and accelerate initiatives that deliver measurable improvements in animal health outcomes and organizational resilience.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Veterinary Medicine Market, by Product Type

  • 8.1. Diagnostics
    • 8.1.1. Imaging
    • 8.1.2. Infectious Disease
  • 8.2. Medicated Feed Additives
  • 8.3. Pharmaceuticals
    • 8.3.1. Generic Drugs
    • 8.3.2. Over The Counter Drugs
    • 8.3.3. Prescription Drugs
  • 8.4. Vaccines
    • 8.4.1. Inactivated
    • 8.4.2. Live Attenuated
    • 8.4.3. Recombinant

9. Veterinary Medicine Market, by Animal Type

  • 9.1. Companion Animal
    • 9.1.1. Cat
    • 9.1.2. Dog
  • 9.2. Equine
  • 9.3. Livestock
    • 9.3.1. Cattle
    • 9.3.2. Poultry
    • 9.3.3. Swine

10. Veterinary Medicine Market, by Therapeutic Area

  • 10.1. Anti Infectives
    • 10.1.1. Antibiotics
    • 10.1.2. Antifungals
    • 10.1.3. Antivirals
  • 10.2. Anti Inflammatories
  • 10.3. Cardiovascular
  • 10.4. Parasiticides
    • 10.4.1. Ectoparasiticides
    • 10.4.2. Endectocides

11. Veterinary Medicine Market, by Route Of Administration

  • 11.1. Inhalation
  • 11.2. Injectable
  • 11.3. Oral
  • 11.4. Topical

12. Veterinary Medicine Market, by Distribution Channel

  • 12.1. Online Stores
  • 12.2. Pharmacies
  • 12.3. Veterinary Clinics

13. Veterinary Medicine Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Veterinary Medicine Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Veterinary Medicine Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Veterinary Medicine Market

17. China Veterinary Medicine Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Archer-Daniels-Midland Company
  • 18.6. Biogenesis Bago SA
  • 18.7. Biopharm company
  • 18.8. Biowet Pulawy sp. z o.o.
  • 18.9. Brovapharma
  • 18.10. C H Boehringer Sohn AG & Co KG
  • 18.11. Ceva Sante Animale
  • 18.12. Dechra Pharmaceuticals PLC
  • 18.13. Elanco Animal Health Incorporated
  • 18.14. Evonik Industries AG
  • 18.15. Hester Biosciences Limited
  • 18.16. Indian Immunologicals Ltd.
  • 18.17. Intracin Pharmaceutical Private Limited
  • 18.18. JoinHub Pharma
  • 18.19. Merck & Co Inc.
  • 18.20. Nam Pharma Sdn Bhd
  • 18.21. NAPHAVET Co., Ltd.
  • 18.22. Neogen Corporation
  • 18.23. Nutreco NV
  • 18.24. Phibro Animal Health Corporation
  • 18.25. Sykes Vet International Pty Ltd.
  • 18.26. TRAVETCO
  • 18.27. Vetoquinol SA
  • 18.28. Vetpharma Animal Health S.L.
  • 18.29. Vetsintez LLC
  • 18.30. Virbac SA
  • 18.31. Weefsel Pharma
  • 18.32. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL VETERINARY MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL VETERINARY MEDICINE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL VETERINARY MEDICINE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES VETERINARY MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA VETERINARY MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL VETERINARY MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INFECTIOUS DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INFECTIOUS DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY GENERIC DRUGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY GENERIC DRUGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY GENERIC DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY OVER THE COUNTER DRUGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY OVER THE COUNTER DRUGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY OVER THE COUNTER DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PRESCRIPTION DRUGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PRESCRIPTION DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY VACCINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY VACCINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INACTIVATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INACTIVATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INACTIVATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY LIVE ATTENUATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY LIVE ATTENUATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY LIVE ATTENUATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY RECOMBINANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY RECOMBINANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY CAT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY CAT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY CAT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DOG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DOG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DOG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY EQUINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY EQUINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY EQUINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY CATTLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY CATTLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY CATTLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY POULTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY POULTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY SWINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY SWINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY SWINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTIBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTIBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTIFUNGALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTIFUNGALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTIFUNGALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTIVIRALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTIVIRALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTIVIRALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTI INFLAMMATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTI INFLAMMATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTI INFLAMMATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ECTOPARASITICIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ECTOPARASITICIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ECTOPARASITICIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ENDECTOCIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ENDECTOCIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ENDECTOCIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INHALATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INHALATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INHALATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY TOPICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ONLINE STORES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ONLINE STORES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ONLINE STORES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 128. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 132. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 133. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 154. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 156. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 160. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA VETERINARY MEDICINE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 188. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 192. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 195. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 196. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 198. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 201. AFRICA VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. AFRICA VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. AFRICA VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 204. AFRICA VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 205. AFRICA VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 206. AFRICA VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. AFRICA VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 208. AFRICA VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 209. AFRICA VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 210. AFRICA VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 211. AFRICA VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 212. AFRICA VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 213. AFRICA VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 215. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 217. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 218. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 219. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 221. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 222. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 223. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 224. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 225. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 227. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 228. ASEAN VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 229. ASEAN VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. ASEAN VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 231. ASEAN VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 232. ASEAN VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 233. ASEAN VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. ASEAN VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 235. ASEAN VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 236. ASEAN VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 237. ASEAN VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 238. ASEAN VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 239. ASEAN VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 240. ASEAN VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 241. GCC VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 242. GCC VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. GCC VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 244. GCC VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 245. GCC VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 246. GCC VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. GCC VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 248. GCC VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 249. GCC VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 250. GCC VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 251. GCC VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 252. GCC VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 253. GCC VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 267. BRICS VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 268. BRICS VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 269. BRICS VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 270. BRICS VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 271. BRICS VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 272. BRICS VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 273. BRICS VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 274. BRICS VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 275. BRICS VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 276. BRICS VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 277. BRICS VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 278. BRICS VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 279. BRICS VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 280. G7 VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 281. G7 VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. G7 VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 283. G7 VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 284. G7 VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 285. G7 VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. G7 VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 287. G7 VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 288. G7 VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 289. G7 VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 290. G7 VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 291. G7 VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 292. G7 VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 293. NATO VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 294. NATO VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 295. NATO VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 296. NATO VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 297. NATO VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 298. NATO VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 299. NATO VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 300. NATO VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 301. NATO VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 302. NATO VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 303. NATO VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 304. NATO VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 305. NATO VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 306. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 307. UNITED STATES VETERINARY MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 308. UNITED STATES VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 309. UNITED STATES VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 310. UNITED STATES VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 311. UNITED STATES VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 312. UNITED STATES VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 313. UNITED STATES VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 314. UNITED STATES VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 315. UNITED STATES VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 316. UNITED STATES VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 317. UNITED STATES VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 318. UNITED STATES VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 319. UNITED STATES VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 320. CHINA VETERINARY MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 321. CHINA VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 322. CHINA VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 323. CHINA VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 324. CHINA VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 325. CHINA VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 326. CHINA VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 327. CHINA VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 328. CHINA VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 329. CHINA VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 330. CHINA VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 331. CHINA VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 332. CHINA VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)